[The cost of sepsis]

Area of Science:

• Clinical research
• Pathophysiology
• Health economics

Context:

• Severe sepsis affects numerous patients annually in Germany and the USA.
• High intensive care unit (ICU) costs are associated with prolonged hospital stays and complex treatments.
• Sepsis imposes a substantial socioeconomic burden, including indirect costs from productivity loss.

Purpose:

• To summarize studies evaluating the direct and indirect costs of sepsis.
• To assess the cost-effectiveness of emerging sepsis therapies.
• To underscore the need for innovative treatments to improve patient outcomes and manage economic impact.

Summary:

• Despite progress in understanding sepsis pathophysiology and developing new treatments, severe sepsis remains a critical healthcare issue.
• The economic impact of sepsis is significant, encompassing high ICU costs and broader societal burdens.
• Innovative drugs and treatment strategies show promise but require careful economic evaluation.

Impact:

• Provides a comprehensive overview of sepsis-related costs and the economic viability of new therapies.
• Informs healthcare providers, policymakers, and researchers on the financial implications of sepsis management.
• Highlights the importance of cost-effective interventions to mitigate the economic burden of sepsis.